Ghusn, W.; Sridharan, M.; Fromer, R.; Ozdemir, M.; Haff, M.G.; Vargas, E.J.
Endoscopic Bariatric Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanistic Insights and Metabolic Implications. Biomedicines 2025, 13, 2437.
https://doi.org/10.3390/biomedicines13102437
AMA Style
Ghusn W, Sridharan M, Fromer R, Ozdemir M, Haff MG, Vargas EJ.
Endoscopic Bariatric Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanistic Insights and Metabolic Implications. Biomedicines. 2025; 13(10):2437.
https://doi.org/10.3390/biomedicines13102437
Chicago/Turabian Style
Ghusn, Wissam, Mira Sridharan, Rachel Fromer, Muhammet Ozdemir, Madeleine G. Haff, and Eric J. Vargas.
2025. "Endoscopic Bariatric Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanistic Insights and Metabolic Implications" Biomedicines 13, no. 10: 2437.
https://doi.org/10.3390/biomedicines13102437
APA Style
Ghusn, W., Sridharan, M., Fromer, R., Ozdemir, M., Haff, M. G., & Vargas, E. J.
(2025). Endoscopic Bariatric Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanistic Insights and Metabolic Implications. Biomedicines, 13(10), 2437.
https://doi.org/10.3390/biomedicines13102437
